资讯
Get the latest on Avidity Biosciences' late-stage RNA drug pipeline, upcoming FDA filings, and market opportunities for rare muscle diseases.
Discover Sagimet Biosciences’ latest innovations in FASN inhibition for MASH and acne. Learn about new clinical trial data and market opportunities.
Undecided with Matt Ferrell on MSN11 小时
Hubitat Hub: Full Smart Home Review
On a quest for the perfect smart home platform, this video reviews the Hubitat Smart Home Hub. It aims to replace SmartThings ...
Prime Minister Shigeru Ishiba announced his resignation on Sunday and instructed his Liberal Democratic Party (LDP) to hold ...
However, effectively integrating semantic understanding into 3DGS in a generalizable way remains a challenge. To overcome these bottlenecks, we introduce SceneSplat, the first end-to-end large-scale ...
10 小时
BusinessWorld on MSNGen Z workers embrace ‘polyworking’ amid low wages, rising costs
Labor group Bukluran ng Manggagawang Pilipino (BMP) blames low wages and contractualization for the rise of polyworking among the youth. Young workers are more vulnerable to becoming polyworkers due ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果